Just for my own peace of mind can we confirm factually that our cells are good for a treatment in covid ards .I'm hearing (from the knockers ) that as a treatment they may be to expensive and required to be given before the symptoms are to bad, which a lot of people receiving them may not need . Then they are not effective on over 65's which are the main group for death and ventilation .If this is correct are we expecting to much for the cells as a preferred treatment of covid ards when the standard of care has seen a big reduction in deaths from covid ards and now the majority of deaths are over 65's .There are also a number of treatments coming out . I know non covid ards is a still a big market . Can any one give thoughts on the above as a discussion i'd just like some clarity ..
- Forums
- ASX - By Stock
- MSB
- $90 a share on COVID ARDS Authorization ?
$90 a share on COVID ARDS Authorization ?, page-228
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.03 |
Change
0.080(8.42%) |
Mkt cap ! $1.176B |
Open | High | Low | Value | Volume |
95.5¢ | $1.03 | 95.0¢ | $43.38M | 42.28M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 72752 | $1.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.03 | 205100 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 1.005 |
5 | 57985 | 1.000 |
1 | 50000 | 0.995 |
2 | 20525 | 0.990 |
1 | 10000 | 0.985 |
Price($) | Vol. | No. |
---|---|---|
1.035 | 190122 | 7 |
1.045 | 39714 | 5 |
1.050 | 21696 | 6 |
1.060 | 9750 | 2 |
1.065 | 5780 | 1 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online